BioCentury | Oct 9, 2020
Translation in Brief

Philogen immunocytokine for glioma; plus Nordic's radiotherapy, Beth Israel Deaconness, Molecular Partners and Alpine

...of MP0420 next month and of MP0423 next half.Alpine’s therapy prevents graft-versus-host diseaseAn Indiana University, Medical University of South Carolina...
...factor Danielle Golovin Fibromun (L19-TNF) ALPN-101 177Lu-satetraxetan-lilotomab, Betalutin (177Lu-DOTA-HH1) MP0420 University of Zurich Swiss Federal Institute of Technology Zurich (ETHZ) Philogen S.p.A. Novartis AG Indiana University Medical University of South Carolina Alpine...
BioCentury | May 30, 2020
Translation in Brief

Empirica’s glioblastoma CAR T therapy in mice; plus tumor microbiomes by tumor type, Senhwa and more

...Gene & Cell Therapy (ASGCT) meeting on May 12. RNA-binding protein as an immune checkpoint Medical University of South Carolina...
...Writer and Karen Tkach Tuzman, Associate Editor CX-5461 American Society of Clinical Oncology ASCO Weizmann Institute of Science McMaster University Empirica Therapeutics Medical University of South Carolina Senhwa...
BioCentury | May 28, 2020
Emerging Company Profile

Atlas-built Q32 debuts with $46M, tissue-targeted complement platform, BMS mAb

...Joshua Thurman, as well as from the lab of Steven Tomlinson, a professor at the Medical University of South Carolina...
...Mass. Technology: Complement-targeting fusion proteins and IL-7R targeted mAb Origin of technology: University of Colorado; Medical University of South Carolina...
BioCentury | Dec 6, 2019
Targets & Mechanisms

A view of immune reprogramming from ASH

...in addition to playing that role in T cells ( No. 2320 ). And a Medical University of South Carolina...
...Other), Jakafi (Other) pevonedistat (MLN4924, TAK-924) American Society of Hematology Takeda Pharmaceutical Co. Ltd. Fudan University National Institutes of Health Dartmouth College Medical University of South Carolina Zhejiang...
BioCentury | Aug 29, 2019
Distillery Therapeutics

SPHK1 in T cells identified as melanoma target

...Ogretmen, Medical University of South Carolina, Charleston, S.C. email: ogretmen@musc.edu CONTACT: Shikhar Mehrotra, same affiliation as above email: mehrotr@musc.edu Claire Quang Medical University of South Carolina Programmed...
BioCentury | Oct 31, 2018
Distillery Therapeutics

Neurology

...published online Oct. 17, 2018 doi:10.1523/JNEUROSCI.1332-18.2018 CONTACT: Jacqueline F. McGinty, Medical University of South Carolina, Charleston, S.C. email: mcginty@musc.edu Claire Quang Medical University of South Carolina Calcium...
BioCentury | Aug 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2018

...3d (C3d) Patient sample and mouse studies suggest inhibiting C3d deposition could help treat stroke Medical University of South Carolina...
BioCentury | Jul 24, 2018
Distillery Therapeutics

Neurology

...published online July 18, 2018 doi:10.1523/JNEUROSCI.0111-18.2018 CONTACT: Stephen Tomlinson, Medical University of South Carolina, Charleston, S.C. email: tomlinss@musc.edu Claire Quang Medical University of South Carolina Complement...
BioCentury | May 30, 2018
Distillery Therapeutics

Neurology

...published online May 16, 2018 doi:10.1126/scitranslmed.aao6459 CONTACT: Stephen Tomlinson, Medical University of South Carolina, Charleston, S.C. email: tomlinss@musc.edu Hongjiang Li Medical University of South Carolina Annexin...
BioCentury | Mar 7, 2018
Distillery Therapeutics

Cancer

...Medical University of South Carolina, Charleston, S.C. email: flemins@musc.edu CONTACT: Chrystal M. Paulos, same affiliation as above email: paulos@musc.edu Hongjiang Li Medical University of South Carolina CD4 CD8 Dipeptidyl...
Items per page:
1 - 10 of 53
BioCentury | Oct 9, 2020
Translation in Brief

Philogen immunocytokine for glioma; plus Nordic's radiotherapy, Beth Israel Deaconness, Molecular Partners and Alpine

...of MP0420 next month and of MP0423 next half.Alpine’s therapy prevents graft-versus-host diseaseAn Indiana University, Medical University of South Carolina...
...factor Danielle Golovin Fibromun (L19-TNF) ALPN-101 177Lu-satetraxetan-lilotomab, Betalutin (177Lu-DOTA-HH1) MP0420 University of Zurich Swiss Federal Institute of Technology Zurich (ETHZ) Philogen S.p.A. Novartis AG Indiana University Medical University of South Carolina Alpine...
BioCentury | May 30, 2020
Translation in Brief

Empirica’s glioblastoma CAR T therapy in mice; plus tumor microbiomes by tumor type, Senhwa and more

...Gene & Cell Therapy (ASGCT) meeting on May 12. RNA-binding protein as an immune checkpoint Medical University of South Carolina...
...Writer and Karen Tkach Tuzman, Associate Editor CX-5461 American Society of Clinical Oncology ASCO Weizmann Institute of Science McMaster University Empirica Therapeutics Medical University of South Carolina Senhwa...
BioCentury | May 28, 2020
Emerging Company Profile

Atlas-built Q32 debuts with $46M, tissue-targeted complement platform, BMS mAb

...Joshua Thurman, as well as from the lab of Steven Tomlinson, a professor at the Medical University of South Carolina...
...Mass. Technology: Complement-targeting fusion proteins and IL-7R targeted mAb Origin of technology: University of Colorado; Medical University of South Carolina...
BioCentury | Dec 6, 2019
Targets & Mechanisms

A view of immune reprogramming from ASH

...in addition to playing that role in T cells ( No. 2320 ). And a Medical University of South Carolina...
...Other), Jakafi (Other) pevonedistat (MLN4924, TAK-924) American Society of Hematology Takeda Pharmaceutical Co. Ltd. Fudan University National Institutes of Health Dartmouth College Medical University of South Carolina Zhejiang...
BioCentury | Aug 29, 2019
Distillery Therapeutics

SPHK1 in T cells identified as melanoma target

...Ogretmen, Medical University of South Carolina, Charleston, S.C. email: ogretmen@musc.edu CONTACT: Shikhar Mehrotra, same affiliation as above email: mehrotr@musc.edu Claire Quang Medical University of South Carolina Programmed...
BioCentury | Oct 31, 2018
Distillery Therapeutics

Neurology

...published online Oct. 17, 2018 doi:10.1523/JNEUROSCI.1332-18.2018 CONTACT: Jacqueline F. McGinty, Medical University of South Carolina, Charleston, S.C. email: mcginty@musc.edu Claire Quang Medical University of South Carolina Calcium...
BioCentury | Aug 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2018

...3d (C3d) Patient sample and mouse studies suggest inhibiting C3d deposition could help treat stroke Medical University of South Carolina...
BioCentury | Jul 24, 2018
Distillery Therapeutics

Neurology

...published online July 18, 2018 doi:10.1523/JNEUROSCI.0111-18.2018 CONTACT: Stephen Tomlinson, Medical University of South Carolina, Charleston, S.C. email: tomlinss@musc.edu Claire Quang Medical University of South Carolina Complement...
BioCentury | May 30, 2018
Distillery Therapeutics

Neurology

...published online May 16, 2018 doi:10.1126/scitranslmed.aao6459 CONTACT: Stephen Tomlinson, Medical University of South Carolina, Charleston, S.C. email: tomlinss@musc.edu Hongjiang Li Medical University of South Carolina Annexin...
BioCentury | Mar 7, 2018
Distillery Therapeutics

Cancer

...Medical University of South Carolina, Charleston, S.C. email: flemins@musc.edu CONTACT: Chrystal M. Paulos, same affiliation as above email: paulos@musc.edu Hongjiang Li Medical University of South Carolina CD4 CD8 Dipeptidyl...
Items per page:
1 - 10 of 53